Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Mangilal Amrutben Shah Foundation, is an unlisted private company incorporated on 11 September, 2020. It is classified as a not for profit company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 15.00 lac and the total paid-up capital is INR 4.00 lac.
The current status of Mangilal Amrutben Shah Foundation is - Active.
Read more
Buy Dashboard using Credits
** All rupee values in INR crores. Based on March 2024 numbers.
8.9%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
* GST not included
** Reports & MCA filings will be based on the latest available financials.
Choose number of credits to buy
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
India
(1)
| State | Type | Address |
|---|---|---|
| Maharashtra | Registered Office | 205, THE SUMMIT BUSINESS BAY, WESTERN EXPRESS HIGHWAY, VILEPARLE (EAST) MUMBAI Mumbai City Maharashtra - 400057 |
Locations on Map
Filter (4)
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Manish Mangilal Shah | 00036482 | 5 years |
| Director | Pushpak Mangilal Shah | 00036507 | 5 years |
| Director | Vikas Mangilal Shah | 00036542 | 5 years |
| Director | Nitin Ganpati Kulkarni | 03042587 | 5 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| TRIHAL PHARMA PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| RESPIPURE PHARMA PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Maharashtra |
| OC SPECIALITIES CHEMICALS PRIVATE LIMITED |
Active
|
80,000.0 | 3 | |
| OC SPECIALITIES PRIVATE LIMITED |
Active
|
25.0 Cr | 3 | |
| BALAJI SOURCINGS PRIVATE LIMITED |
Active
|
3.0 Cr | 2 | Maharashtra |
| NAVIN FLUORINE ADVANCED SCIENCES LIMITED |
Active
|
840.3 Cr | 1 | |
| NAVIN FLUORINE INTERNATIONAL LIMITED |
Active
|
9.9 Cr | 1 |
Severe Risk
Moderate Risk
Low Risk
Read more
The incorporation date of MANGILAL AMRUTBEN SHAH FOUNDATION is 11 September, 2020
The authorized share capital of MANGILAL AMRUTBEN SHAH FOUNDATION is INR ₹ 15.0 L.
The paid-up capital of MANGILAL AMRUTBEN SHAH FOUNDATION is INR ₹ 4.0 L.
The registered address of MANGILAL AMRUTBEN SHAH FOUNDATION is 205, THE SUMMIT BUSINESS BAY, WESTERN EXPRESS HIGHWAY, VILEPARLE (EAST) MUMBAI Mumbai City Maharashtra - 400057
The CIN number of MANGILAL AMRUTBEN SHAH FOUNDATION is U85300MH2020NPL345883.
Expand
Delete
Collapse
See
details
